Whittier Trust CO Seagen Inc. Transaction History

Whittier Trust CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$191.51 - $216.16 $8,809 - $9,943	46 Added 2.56%	1,844 $391,000
Q2 2023 Jul 24, 2023	SELL	$187.64 - $206.25 $403,425 - $443,437	-2,150 Reduced 54.46%	1,798 $346,000
Q1 2023 Apr 21, 2023	BUY	$127.59 - $203.08 $325,226 - $517,650	2,549 Added 182.2%	3,948 $799,000
Q1 2022 Apr 29, 2022	SELL	$119.61 - $157.85 $6,339 - $8,366	-53 Reduced 3.65%	1,399 $202,000
Q4 2021 Jan 19, 2022	BUY	$142.57 - $190.86 $97,375 - $130,357	683 Added 88.82%	1,452 $224,000

Q2 2021 Jul 29, 2021	SELL	$135.08 - $161.1 $20,262 - $24,165	-150 Reduced 16.32%	769 $121,000
Q1 2021 Apr 26, 2021	BUY	$137.51 - $190.8 $20,626 - $28,620	150 Added 19.51%	919 $128,000
Q4 2020 Jan 29, 2021	BUY	$164.63 - $211.93 $126,600 - $162,974	769 New	769 $135,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

Stay updated on Whittier Trust CO with notifications on news.